Fiji vs Indonesia: Treatment coverage for lymphatic filariasis
Fiji
41.7%
in 2023
Indonesia
51.8%
in 2024
Fiji rank
43rd
Indonesia rank
41st
Treatment coverage for lymphatic filariasis over time
- Fiji
- Indonesia
How they compare
Indonesia currently reports 51.8% against 41.7% in Fiji, a difference of 10.1%.
That makes Indonesia's figure about 1.2 times Fiji's.
The two have swapped places 7 times across 22 shared years of data; in 2002 it was Fiji ahead.
Fiji ranks 43rd and Indonesia ranks 41st of 66 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Indonesia in 1.
Head to head by decade
| Decade | Fiji | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.8% | 5.2% | 44.5% | Fiji |
| 2010s | 64.1% | 45.8% | 18.3% | Fiji |
| 2020s | 15.4% | 51.9% | 36.5% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Fiji or Indonesia?
- Indonesia, at 51.8% against 41.7% in Fiji as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Fiji and Indonesia?
- 10.1%, with Indonesia ahead.
- How many years of comparable data are there for Fiji and Indonesia?
- 22 years are reported by both, from 2002 to 2023.
- How do Fiji and Indonesia rank globally for treatment coverage for lymphatic filariasis?
- Fiji ranks 43rd and Indonesia ranks 41st of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.